Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BHV-2100

(Synonyms: Ponometrep) Copy Product Info
🥰Excellent

Synonyms: Ponometrep

Catalog No. T217528 Copy Product Info
Purity: 98.13%
🥰Excellent
BHV-2100 is an orally active, selective TRPM3 ion channel antagonist that attenuates pain signals by inhibiting TRPM3-mediated Ca²⁺ influx and CGRP release. It is primarily used in research on migraine and pain-related conditions.

BHV-2100

Cas No. 2776175-74-5
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$68-In Stock
5 mg$163-In Stock
10 mg$268-In Stock
25 mg$538-In Stock
50 mg$855-In Stock
100 mg$1,260-In Stock
1 mL x 10 mM (in DMSO)$175-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.13%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
BHV-2100 is an orally active, selective TRPM3 ion channel antagonist that attenuates pain signals by inhibiting TRPM3-mediated Ca²⁺ influx and CGRP release. It is primarily used in research on migraine and pain-related conditions.
Targets & IC50
TRPM3:1-10 nM
In vitro
BHV-2100 inhibits TRPM3 in humans, mice, and rats, with an IC₅₀ value of 1–10 nM [1].
In vivo
BHV-2100 (Ponometrep) can suppress PS-induced pain responses in mice and rats, with ED₅₀ values of 1.3 mg/kg and 2.5 mg/kg, respectively [1].
SynonymsPonometrep
Chemical Properties
Molecular Weight389.43
FormulaC18H19N3O5S
Cas No.2776175-74-5
SmilesC(N[C@H](C(N)=O)CO)(=O)C=1C=2C(OC1C)=CC=C(OCC=3SC(C)=NC3)C2
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (102.71 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5679 mL12.8393 mL25.6786 mL128.3928 mL
5 mM0.5136 mL2.5679 mL5.1357 mL25.6786 mL
10 mM0.2568 mL1.2839 mL2.5679 mL12.8393 mL
20 mM0.1284 mL0.6420 mL1.2839 mL6.4196 mL
50 mM0.0514 mL0.2568 mL0.5136 mL2.5679 mL
100 mM0.0257 mL0.1284 mL0.2568 mL1.2839 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: BHV-2100 in vivo | BHV-2100 in vitro | BHV-2100 formula | BHV-2100 molecular weight